Marin-Bejar O., Romero-Moya D., Rodriguez-Ubreva J., Distefano M., Lessi F., Aretini P., Liquori A., Castaño J., Kozyra E., Kotmayer L., Bueno C., Cervera J., Rodriguez-Gallego J.C., Nomdedeu J.F., Murillo-Sanjuán L., De Heredia C.D., Pérez-Martinez A., López-Cadenas F., Martínez-Laperche C., Dorado-Herrero N., Marco F.M., Prósper F., Menendez P., Valcárcel D., Ballestar E., Bödör C., Bigas A., Catalá A., Wlodarski M.W., Giorgetti A.. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. HAEMATOLOGICA. 2023; 108(9)DOI:10.3324/haematol.2022.282305. PMID:36815365. IF:10.100(Q1/2D).

Ventura-Cots, M, Argemi, J, Jones, PD, Lackner, C, El Hag, M, Abraldes, JG, Alvarado, E, Clemente, A, Ravi, S, Alves, A, Alboraie, M, Altamirano, J, Barace, S, Bosques, F, Brown, R, Caballeria, J, Cabezas, J, Carvalhana, S, Cortez-Pinto, H, Costa, A, Degre, D, Fernandez-Carillo, C, Ganne-Carrie, N, Garcia-Tsao, G, Genesca, J, Koskinas, J, Lanthier, N, Louvet, A, Lozano, JJ, Lucey, MR, Masson, S, Mathurin, P, Mendez-Sanchez, N, Miquel, R, Moreno, C, Mounajjed, T, Odena, G, Kim, W, Sancho-Bru, P, Sands, RW, Szafranska, J, Verset, L, Schnabl, B, Sempoux, C, Shah, VJ, Shawcross, DL, Stauber, RE, Straub, BK, Verna, E, Tiniakos, D, Trepo, E, Vargas, V, Villanueva, C, Woosley, JT, Ziol, M, Mueller, S, Starkel, P, Bataller, R. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. GUT. 2022; 71(9)DOI:10.1136/gutjnl-2021-324295. PMID:34992134. IF:24.500(Q1/1D).

Marsico, S, Orellana-Fernandez, R, Tizon-Marcos, H, Mas-Stachurska, A, Solano, A, Zuccarino, F. Multimodality imaging evaluation of a primary cardiac epithelioid hemangioendothelioma. ACTA CARDIOLOGICA. 2022; 77(6)DOI:10.1080/00015385.2021.1908704. PMID:33827376. IF:1.600(Q4/9D).

Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).

Pasquali, S, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Lopez-Pousa, A, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Diaz-Beveridge, R, Ferraresi, V, Lugowska, I, Infante, G, Braglia, L, Merlo, DF, Fontana, V, Marchesi, E, Donati, DM, Palassini, E, Bianchi, G, Marrari, A, Morosi, C, Stacchiotti, S, Bague, S, Coindre, JM, Dei Tos, AP, Picci, P, Bruzzi, P, Miceli, R, Casali, PG, Gronchi, A. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. CANCER. 2022; 128(1)DOI:10.1002/cncr.33895. PMID:34643947. IF:6.200(Q1/3D).

Moura, DS, Pena-Chilet, M, Varela, JAC, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ramos, R, Ortega-Medina, L, Martin-Davila, F, Castilla-Ramirez, C, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Vicioso, L, Barcelo, JEH, Rubio-Casadevall, J, de Juan, A, Fiano-Valverde, MC, Hindi, N, Lopez-Alvarez, M, Lacerenza, S, Dopazo, J, Gutierrez, A, Alvarez, R, Valverde, C, Martinez-Trufero, J, Martin-Broto, J. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin. Molecular Oncology. 2021; 15(12)DOI:10.1002/1878-0261.12996. PMID:33983674. IF:7.449(Q1/3D).